Ingeborg Rasing1, Ynte M Ruigrok2, Paut Greebe1, Birgitta K Velthuis1, Theo D Witkamp1, Marieke J H Wermer1, Yvo B Roos1, W Peter Vandertop1, Gabriel J E Rinkel1. 1. From the Department of Neurology and Neurosurgery (I.R., Y.M.R., P.G., B.K.V., T.D.W., G.J.E.R.), Brain Centre Rudolf Magnus, University Medical Centre Utrecht; Leids Universitair Medisch Centrum (I.R., M.J.H.W.), Department of Neurology, Leiden; Neurosurgical Centre Amsterdam (Y.B.R., W.P.V.), Academic Medical Centre Amsterdam and VU University Medical Centre, Amsterdam, the Netherlands. 2. From the Department of Neurology and Neurosurgery (I.R., Y.M.R., P.G., B.K.V., T.D.W., G.J.E.R.), Brain Centre Rudolf Magnus, University Medical Centre Utrecht; Leids Universitair Medisch Centrum (I.R., M.J.H.W.), Department of Neurology, Leiden; Neurosurgical Centre Amsterdam (Y.B.R., W.P.V.), Academic Medical Centre Amsterdam and VU University Medical Centre, Amsterdam, the Netherlands. ij.m.ruigrok@umcutrecht.nl.
Abstract
OBJECTIVE: The objective was to assess the risk of aneurysmal subarachnoid hemorrhage (aSAH) in the initial 15 years after negative aneurysm screening in persons with one first-degree relative with aSAH. METHODS: From a cohort of first-degree relatives of patients with aSAH who underwent screening between 1995 and 1997 (n = 626), we included those with a negative screening (n = 601). We retrieved all causes of death and sent a questionnaire to screenees who were still alive. If aSAH was reported, we reviewed all medical data. We assessed the incidence of aSAH in this cohort with survival analysis and calculated an incidence ratio by dividing the observed incidence with the age- and sex-adjusted incidence in the general population. RESULTS: Of the 601 screenees, 3 had aSAH during 8,938 follow-up patient-years (mean 14.9 years). After 15 years, the cumulative incidence was 0.50% (95% confidence interval: 0.00%-1.06%) with an incidence rate of 33.6 per 100,000 person-years; the incidence rate ratio was 1.7 (95% confidence interval: 0.3-5.7). CONCLUSIONS: In the first 15 years after a negative screening, the risk of aSAH in persons with one first-degree relative with aSAH is not nil, but in the range of that in the general population, or even higher. Whether this finding justifies serial aneurysm screening in this population requires further study.
OBJECTIVE: The objective was to assess the risk of aneurysmal subarachnoid hemorrhage (aSAH) in the initial 15 years after negative aneurysm screening in persons with one first-degree relative with aSAH. METHODS: From a cohort of first-degree relatives of patients with aSAH who underwent screening between 1995 and 1997 (n = 626), we included those with a negative screening (n = 601). We retrieved all causes of death and sent a questionnaire to screenees who were still alive. If aSAH was reported, we reviewed all medical data. We assessed the incidence of aSAH in this cohort with survival analysis and calculated an incidence ratio by dividing the observed incidence with the age- and sex-adjusted incidence in the general population. RESULTS: Of the 601 screenees, 3 had aSAH during 8,938 follow-up patient-years (mean 14.9 years). After 15 years, the cumulative incidence was 0.50% (95% confidence interval: 0.00%-1.06%) with an incidence rate of 33.6 per 100,000 person-years; the incidence rate ratio was 1.7 (95% confidence interval: 0.3-5.7). CONCLUSIONS: In the first 15 years after a negative screening, the risk of aSAH in persons with one first-degree relative with aSAH is not nil, but in the range of that in the general population, or even higher. Whether this finding justifies serial aneurysm screening in this population requires further study.
Authors: A Ronkainen; J Hernesniemi; M Puranen; L Niemitukia; R Vanninen; M Ryynänen; H Kuivaniemi; G Tromp Journal: Lancet Date: 1997-02-08 Impact factor: 79.321
Authors: N K de Rooij; F H H Linn; J A van der Plas; A Algra; G J E Rinkel Journal: J Neurol Neurosurg Psychiatry Date: 2007-04-30 Impact factor: 10.154
Authors: A S E Bor; G J E Rinkel; J Adami; H Koffijberg; A Ekbom; E Buskens; P Blomqvist; F Granath Journal: Brain Date: 2008-09-26 Impact factor: 13.501
Authors: Joseph P Broderick; Robert D Brown; Laura Sauerbeck; Richard Hornung; John Huston; Daniel Woo; Craig Anderson; Guy Rouleau; Dawn Kleindorfer; Matthew L Flaherty; Irene Meissner; Tatiana Foroud; E Charles J Moomaw; E Sander Connolly Journal: Stroke Date: 2009-02-19 Impact factor: 7.914